Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 2,349 shares at $6.10 ($14K) on 2024-03-19, disclosed to the SEC on 2024-03-19.
Open-market sale of $14k STOK by GENERAL COUNSEL & Corporate Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |